Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from United rapeutics

Dow Jones Futures Rise: Will Market Rally Follow Up? Nine Stocks Flash Buy Signals

The major indexes and leading stocks jumped Friday on Fed-friendly economic data. A bullish turn or another head fake?

Investors Business Daily

IBD Stock Of The Day United Therapeutics Is Braving Competition, And Eyeing Two Entries

IBD Stock Of The Day United Therapeutics Is Braving Competition, And Eyeing Two Entries

United Therapeutics is the IBD Stock Of The Day as competition heats up in its lung disease market. UTHR stock is eyeing two potential buy points.

Investors Business Daily

Biotech Stocks Are Heating Up, But We're Still Light On Swing Trading

Biotech Stocks Are Heating Up, But We're Still Light On Swing Trading

Many stocks showing relative strength now hail from the medical sector. Here's a swing trading example with UTHR stock.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Biotech Stock United Therapeutics Revives Breakout, Retakes Buy Zone

Biotech stock United Therapeutics joins peers Vertex and Harmony Biosciences on the Breakout Stocks Index as it reenters a buy zone.

Investors Business Daily

Will Investors Notice Exciting Sign On United Therapeutics's Chart?

If history is any guide, there may be good fortune ahead for shares of United Therapeutics (NASDAQ:UTHR). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Oil Stocks Lead Charge Of Breakouts And Buy Zones In New Uptrend

With a new uptrend underway, oil stocks like TotalEnergies and tech stocks like Synopsys set the stage for new breakouts.

Investors Business Daily

United Therapeutics Stock Sees RS Rating Jump To 89; Earns 'Blue Dot'

A Relative Strength Rating upgrade for United Therapeutics shows improving technical performance.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings for United Therapeutics

Expert Ratings for United Therapeutics

Within the last quarter, United Therapeutics (NASDAQ:UTHR) has observed the following analyst ratings:

United Therapeutics's Return on Invested Capital Insights

United Therapeutics's Return on Invested Capital Insights

According to Benzinga Pro, during Q1, United Therapeutics (NASDAQ:UTHR) earned $239.90 million, a 113.81% increase from the preceding quarter. United Therapeutics also posted a total of $461.90 million in sales, a 11.25% increase since Q4.

Recap: United Therapeutics Q1 Earnings

Recap: United Therapeutics Q1 Earnings

United Therapeutics (NASDAQ:UTHR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Earnings Outlook For United Therapeutics

Earnings Outlook For United Therapeutics

United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $3.34.

United Therapeutics Q1 2022 Earnings Conference Call On May 4, 2022 At 09:00 AM ET

United Therapeutics Q1 2022 Earnings Conference Call On May 4, 2022 At 09:00 AM ET

United Therapeutics (NASDAQ:UTHR) will host a conference call at 09:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend United Therapeutics (UTHR) Conference Call Follow this link to access the live webcast.

United Therapeutics Earnings Perspective: Return On Capital Employed

United Therapeutics Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, United Therapeutics (NASDAQ:UTHR) posted Q4 earnings of $112.20 million, an increase from Q3 of 31.04%. Sales dropped to $415.20 million, a 6.63% decrease between quarters.

United Therapeutics's Earnings Outlook

United Therapeutics's Earnings Outlook

United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $3.72.

Get all your
news in one place.

100’s of premium titles.
One news app.

1

Organisations

US Federal Reserve

Vertex Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

231,450 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play